45
Growth Score
pts
Heat Score
-35 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
971224
EliteImmune develops antibody-based drugs for infectious diseases using proprietary CellProbe™ technology.
- Xuelian Zhao: Founder and Chief Executive Officer
About the Company
EliteImmune is a biotechnology company dedicated to developing antibody-based drugs for the targeted therapy and prophylaxis of infectious diseases. Utilizing its proprietary CellProbe™ technology, EliteImmune aims to advance the field of infectious disease treatment by creating innovative solutions. The company's research and development
efforts are spearheaded by a team of talented scientists specializing in microbiology, virology, protein characterization, antiviral therapeutics, vaccines, and assay development. EliteImmune's commitment to addressing global health challenges is reflected in its focus on harnessing the power of the immune system to fight infections effectively.
